These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6572395)
1. Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate. Heath TD; Montgomery JA; Piper JR; Papahadjopoulos D Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1377-81. PubMed ID: 6572395 [TBL] [Abstract][Full Text] [Related]
2. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles. Matthay KK; Heath TD; Papahadjopoulos D Cancer Res; 1984 May; 44(5):1880-6. PubMed ID: 6713389 [TBL] [Abstract][Full Text] [Related]
3. New methodology for liposome targeting to specific cells. Papahadjopoulos D; Heath T; Bragman K; Matthay K Ann N Y Acad Sci; 1985; 446():341-8. PubMed ID: 2861775 [TBL] [Abstract][Full Text] [Related]
4. Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition. Berinstein N; Matthay KK; Papahadjopoulos D; Levy R; Sikic BI Cancer Res; 1987 Nov; 47(22):5954-9. PubMed ID: 3664498 [TBL] [Abstract][Full Text] [Related]
5. The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro. Heath TD; Lopez NG; Papahadjopoulos D Biochim Biophys Acta; 1985 Oct; 820(1):74-84. PubMed ID: 3876848 [TBL] [Abstract][Full Text] [Related]
6. Leakage and delivery of liposome-encapsulated methotrexate-gamma-aspartate in a chemically defined medium. Comiskey SJ; Heath TD Biochim Biophys Acta; 1990 May; 1024(2):307-17. PubMed ID: 2354182 [TBL] [Abstract][Full Text] [Related]
7. In vitro drug delivery mediated by ecto-NAD+-glycohydrolase ligand-targeted liposomes. Salord J; Schuber F Biochim Biophys Acta; 1988 Sep; 971(2):197-206. PubMed ID: 3167100 [TBL] [Abstract][Full Text] [Related]
9. Liposome-mediated delivery of pteridine antifolates to cells in vitro: potency of methotrexate, and its alpha and gamma substituents. Heath TD; Lopez NG; Piper JR; Montgomery JA; Stern WH; Papahadjopoulos D Biochim Biophys Acta; 1986 Nov; 862(1):72-80. PubMed ID: 3768370 [TBL] [Abstract][Full Text] [Related]
10. Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery. Matthay KK; Heath TD; Badger CC; Bernstein ID; Papahadjopoulos D Cancer Res; 1986 Oct; 46(10):4904-10. PubMed ID: 3756852 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of antibody-directed liposomes that recognize two receptors on K562 cells. Bragman KS; Heath TD; Papahadjopoulos D J Natl Cancer Inst; 1984 Jul; 73(1):127-31. PubMed ID: 6588220 [TBL] [Abstract][Full Text] [Related]
12. Liposome-dependent delivery of pteridine antifolates: a two-compartment growth inhibition assay for evaluating drug leakage and metabolism. Ng KY; Heath TD Biochim Biophys Acta; 1989 Jun; 981(2):261-8. PubMed ID: 2730904 [TBL] [Abstract][Full Text] [Related]
13. Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes. Straubinger RM; Lopez NG; Debs RJ; Hong K; Papahadjopoulos D Cancer Res; 1988 Sep; 48(18):5237-45. PubMed ID: 3409248 [TBL] [Abstract][Full Text] [Related]
14. Interactions of immunoliposomes with target cells. Huang A; Kennel SJ; Huang L J Biol Chem; 1983 Nov; 258(22):14034-40. PubMed ID: 6358213 [TBL] [Abstract][Full Text] [Related]
15. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Matthay KK; Abai AM; Cobb S; Hong K; Papahadjopoulos D; Straubinger RM Cancer Res; 1989 Sep; 49(17):4879-86. PubMed ID: 2788031 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643 [TBL] [Abstract][Full Text] [Related]
17. Effect of liposomes containing sodium butyrate conjugated with anti-CD19 monoclonal antibody on in vitro and in vivo growth of malignant lymphoma. Watanabe M; Pesando JM; Hakomori S Cancer Res; 1990 Jun; 50(11):3245-8. PubMed ID: 1692257 [TBL] [Abstract][Full Text] [Related]
18. Small liposomes are better than large liposomes for specific drug delivery in vitro. Machy P; Leserman LD Biochim Biophys Acta; 1983 May; 730(2):313-20. PubMed ID: 6849906 [TBL] [Abstract][Full Text] [Related]
19. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo. Shi C; Cao H; He W; Gao F; Liu Y; Yin L Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of methotrexate encapsulated in cationic liposomes (EndoMTX) in comparison to free methotrexate in an antigen-induced arthritis study in vivo. Gottschalk O; Metz P; Dao Trong ML; Altenberger S; Jansson V; Mutschler W; Schmitt-Sody M Scand J Rheumatol; 2015; 44(6):456-63. PubMed ID: 26114440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]